The id.DRIVE consortium has taken another important step in the expansion of its international study network with the successful completion […]
Category: Newsroom
The 2025–2026 id.DRIVE studies reached the 10,000-patient recruitment milestone, bringing total enrolment over 40,000 participants since 2021.
The id.DRIVE partnership is pleased to announce that recruitment for the 2025–2026 epidemiological year already reached over 10,000 patients—hitting our […]
id.DRIVE Site Investigators Meeting 2026: advancing study quality, operational efficiency and preparedness
On 21 April 2026,the id.DRIVE study team, site collaborators and partners convened in Munich, Germany, for the annual id.DRIVE Site Investigators Meeting. The […]
id.DRIVE announces strategic expansion of study network to Canada
The id.DRIVE consortium is proud to announce the expansion of its observational infectious diseases research platform to Canada, marking a […]
id.DRIVE showcases RSV research at ReSViNET 2026 conference in Italy
From 17–20 February 2026, the ReSViNET – Respiratory Syncytial Virus (RSV) Foundation held its 9thinternational conference in Rome, bringing together global experts […]
id.DRIVE launches pilot study to assess potential underestimation of RSV, hMPV, and PIV detection rates.
id.DRIVE launched a new prospective cohort pilot study to investigate whether respiratory syncytial virus (RSV) and other respiratory viruses may […]
id.DRIVE celebrates 5 years of advancing respiratory infectious diseases and vaccine research in Europe
7 December 2025 — Today marks the five-year anniversary of id.DRIVE, a milestone that reflects half a decade of commitment […]
id.DRIVE partners gather in Leuven for the 2025 Steering Committee meeting
On 12 and 13th of November, the id.DRIVE Steering Committee convened in Leuven, Belgium, for its annual in-person meeting. Over two […]
The id.DRIVE studies reach 25,000 patients — A major milestone on our mission to build a large and sustainable platform for respiratory pathogens and vaccines research
We are proud to announce that the id.DRIVE partnership has officially recruited 25,000 patients across our three studies (surveillance, COVID-19 and RSV […]
The id.DRIVE Partnership launches its 2025–2026 Epidemiological Year with three studies
The 1st September 2025 marks the official start of the 2025–2026 epidemiological year for the id.DRIVE studies, kicking off another […]